Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

185
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
185
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

201
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
201
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

239
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
239
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

171
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
171
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

193
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
193
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

250
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
250

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Patterns of presentation and outcomes in stage IV Hodgkin lymphoma: A report from the Children's Oncology Group (COG) AHOD1331 trial.

British journal of haematology·2026
Same author

Community-Based Organizations, Indian Health Services, and Rural Federally Qualified Health Center Collaborative: Patient navigation along the cancer care continuum.

Journal of health care for the poor and underserved·2026
Same author

Cancer Screening Adherence in the US by Smoking and Vaping Status, 2023.

Cancer prevention research (Philadelphia, Pa.)·2026
Same author

E Lesion or Stage IV disease? An Ongoing Unsettled Issue in Pediatric Hodgkin Lymphoma.

Blood advances·2026
Same author

Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Development and pre-testing of a family-centered digital intervention to help families know what to EXPECT from pediatric acute lymphoblastic leukemia therapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

相关实验视频

Updated: Jan 13, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.9K

医疗支持多层次干预,以加强对儿科药物坚持的支持:开发和可行性测试.

Elizabeth G Bouchard1, Hital Patel1, Paula C Vincent1

  • 1Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.

Pediatric blood & cancer
|January 10, 2026
PubMed
概括

针对儿科急性淋巴细胞白血病 (ALL) 患者的干预措施MedSupport在试点研究中显示出在护理人员和医疗保健提供者中具有很高的可行性和可接受性. 需要进一步的研究来证实它在改善药物坚持方面的有效性.

关键词:
坚持性 坚持性行为研究 行为研究研究结果研究成果.儿科瘤学 儿科瘤学这是心理社会心理社会.

更多相关视频

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

6.3K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.8K

相关实验视频

Last Updated: Jan 13, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.9K
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

6.3K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.8K

科学领域:

  • 儿科瘤学 儿科瘤学
  • 药理学 药理学是指药理学的学科.
  • 医疗保健服务研究 医疗服务研究

背景情况:

  • 药物坚持对于儿科急性淋巴细胞白血病 (ALL) 治疗的有效性至关重要.
  • 现有的干预措施往往无法解决复杂的坚持障碍.
  • MedSupport干预措施是为了针对这些根本原因而开发的.

研究的目的:

  • 评估MedSupport干预措施的可行性和可接受性.
  • 为未来的全规模随机对照试验收集初步数据.
  • 评估该干预措施在改善家庭化疗坚持性方面的潜力.

主要方法:

  • 在罗斯韦尔公园进行了一项试点研究,涉及口服化疗的儿科ALL患者的护理人员和医疗保健提供者.
  • 通过参与率,填写查问卷和干预忠实度来评估可行性.
  • 接受度是使用标准化自我报告尺度来衡量护理人员和医疗保健提供者的接受度.

主要成果:

  • 100%的符合条件的护理人员和医疗保健提供者同意参与,显示了高需求.
  • 所有参与家庭都完成了粘附障碍查,所有家庭都认可障碍.
  • 护理人员和医疗保健提供者都认为MedSupport干预非常可接受,适当和可行.
  • 客观措施证实了捕捉干预忠诚度和展示参与的可行性.

结论:

  • 医疗支持干预是一种可行,可接受,低成本和可扩展的方法.
  • 这项试点研究为未来对MedSupport疗效的研究提供了坚实的基础.
  • 需要进一步的研究,以确定MedSupport在提高儿科ALL患者的药物坚持方面的有效性.